Related references
Note: Only part of the references are listed.The Relationship Between Inflammation and Impaired Wound Healing in a Diabetic Rat Burn Model
Ming Tian et al.
JOURNAL OF BURN CARE & RESEARCH (2016)
Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
Carmel M. McVicar et al.
DIABETOLOGIA (2015)
Nε-(Carboxymethyl) lysine- Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance
Katrien H. J. Gaens et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: Randomized controlled trial (PioRAGE)
Hidenori Koyama et al.
ATHEROSCLEROSIS (2014)
Effects of Advanced Glycation End Products on Calcium Handling in Cardiomyocytes
Dewen Yan et al.
CARDIOLOGY (2014)
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
Fei Song et al.
DIABETES (2014)
Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients
Katsuyuki Yanagisawa et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Up-Regulation of the Receptor for Advanced Glycation End Products in the Skin Biopsy Specimens of Patients with Severe Diabetic Neuropathy
Su-Yeon Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2014)
Low Levels of Serum Soluble Receptors for Advanced Glycation End Products, Biomarkers for Disease State: Myth or Reality
Kailash Prasad
INTERNATIONAL JOURNAL OF ANGIOLOGY (2014)
Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
Francesco Piarulli et al.
ACTA DIABETOLOGICA (2013)
Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease
Donavan T. Cheng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Katrien H. J. Gaens et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice
Judyta K. Juranek et al.
DIABETES (2013)
Physiological roles of Rho and Rho effectors in mammals
Dean Thumkeo et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2013)
Complex Tissue-Specific Patterns and Distribution of Multiple RAGE Splice Variants in Different Mammals
Raquel Lopez-Diez et al.
GENOME BIOLOGY AND EVOLUTION (2013)
Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells
Sergey Reverdatto et al.
PLOS ONE (2013)
Cardiac Fibroblast-Dependent Extracellular Matrix Accumulation Is Associated with Diastolic Stiffness in Type 2 Diabetes
Kirk R. Hutchinson et al.
PLOS ONE (2013)
被撤回的出版物: The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice (Retracted article. See vol. 9, e108684, 2014)
Dajeong Lee et al.
PLOS ONE (2013)
High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products
Yuji Nadatani et al.
PLOS ONE (2013)
Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways
Fatouma Toure et al.
CIRCULATION RESEARCH (2012)
The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity
J. M. Brix et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
Vivek Rai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
Vivek Rai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)
Barry I. Hudson et al.
ATHEROSCLEROSIS (2011)
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
Xystus H. L. Tam et al.
CLINICAL SCIENCE (2011)
Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes An Analysis From the CARDS Trial
Helen M. Colhoun et al.
DIABETES (2011)
Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure
Ling Jie Wang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release
Roberta Bianchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of advanced glycation endproduct formation by foodstuffs
Chi-Hao Wu et al.
FOOD & FUNCTION (2011)
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy
Suganthalakshmi Balasubbu et al.
BMC MEDICAL GENETICS (2010)
Activation of the ROCK1 Branch of the Transforming Growth Factor-β Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice
De-xiu Bu et al.
CIRCULATION RESEARCH (2010)
Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
Nina Reiniger et al.
DIABETES (2010)
Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages
Yunlu Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Diabetic cardiomyopathy, causes and effects
Sihem Boudina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
The Role of Impaired Mitochondrial Lipid Oxidation in Obesity
Mary Madeline Rogge
BIOLOGICAL RESEARCH FOR NURSING (2009)
Soluble forms of RAGE in internal medicine
Natale Vazzana et al.
INTERNAL AND EMERGENCY MEDICINE (2009)
Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels
Katrien H. J. Gaens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
Giuseppe Danilo Norata et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
RAGE ligation affects T cell activation and controls T cell differentiation
Yali Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Decreased plasma soluble RAGE in patients with hypercholesterolemia:: Effects of statins
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein
Gunther Marsche et al.
FASEB JOURNAL (2007)
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
K. C. B. Tan et al.
DIABETOLOGIA (2007)
Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India
S. Ramprasad et al.
EYE (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Diego Geroldi et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice
LJN Jensen et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
N Demling et al.
CELL AND TISSUE RESEARCH (2006)
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
H Koyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Polymorphisms of the Receptor of Advanced Glycation Endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients
G Prevost et al.
DIABETES & METABOLISM (2005)
Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation
K Wear-Maggitti et al.
ANNALS OF PLASTIC SURGERY (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The role of advanced glycation end products in retinal microvascular leukostasis
TCB Moore et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
The formins: active scaffolds that remodel the cytoskeleton
BJ Wallar et al.
TRENDS IN CELL BIOLOGY (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
LG Bucciarelli et al.
CIRCULATION (2002)
ROCK and Dia have opposing effects on adherens junctions downstream of Rho
E Sahai et al.
NATURE CELL BIOLOGY (2002)
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
MT Goova et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
